SEC Form 5 · accession 0001547522-16-000211
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Cox
Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 16, 2016 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | holding | — | — | — | 67,555 | D |
Table II — derivative securities
No Table II lines on this filing.